80 percent of A/H1N1 flu deaths are pregnant women
80 percent of A/H1N1 flu deaths are pregnant women
16:09, December 09, 2009
Statistics show that to date, 80 percent of over 200 A/H1N1 flu deaths in China have been pregnant women, and the majority of them had been pregnant for more than six months, said academician Zhong Nanshan when he visited health service centers in the Jiangnan Zhongjie Community, Haizhu District December 8.
It is more convenient for A/H1N1 patients to go to community hospitals
Zhong said during his visit to the health service centers, that about half of Guangzhou's patients who saw doctors because of having a cold or fever were flu patients, 90 percent of which were A/H1N1 patients. It is more convenient for A/H1N1 patients to go to community hospitals than large-sized hospitals.
Zhong noted that ordinary treatment is enough for most patients with mild symptoms. Aside from providing treatment services, community health service centers also play a monitoring role. "If there are more flu patients, community health service centers should report to departments at a higher level; if there are many flu patients in a community, the community health service center should take timely preventive and control measures such as quarantine to prevent the spread of the epidemic. Patients can immediately access treatment at community health service centers after contracting the flu, this is the most effective method to prevent and control the A/H1N1 flu," said Zhong.
Pregnant women with A/H1N1 flu symptoms should take the Tamiflu as early as possible
Zhong disclosed that statistics show 80 percent of the over 200 A/H1N1 flu deaths in China have been pregnant women, and the majority of them had been pregnant for more than six months.
Zhong added that once the condition of pregnant women who contracted A/H1N1 flu became severe, it is very difficult to cure and there is a high rate of fetal mortality. He suggested that pregnant women who have A/H1N1 flu symptoms such as fever or cough should receive the Tamiflu injection.
Zhong suggested the community health service centers pay close attention to high-risk groups, such as pregnant women of five to six months and people who have suffered from heart disease or asthma in the past. The A/H1N1 patients who suffer with persistent high fever, body aches and cough, or whose condition worsens quickly in two or three days, should take the Tamiflu as soon as possible.
Zhong also disclosed that at present, China has reserved 26 million doses of Tamiflu, which account for 2 percent of China's population. The Tamiflu will initially be delivered to provinces and cities, and then to villages and communities.
State Food and Drug Administration (SFDA) reaffirmed that the A/H1N1 vaccine is safe.
The SFDA held a routine press conference on December 8.
In the conference, spokesperson Yan Jiangying reaffirmed in terms of the safety of the A/H1N1 vaccine that the Ministry of Health had specially explained the four death cases. The cases occurred after the patients were vaccinated, but they were not directly related to the vaccine. So far, no allergic response to the A/H1N1 vaccine has been found, and the vaccine is safe and effective. Although the SFDA finished the vaccine's examination and approval in a short period of time, the standards were not degraded and the procedures were not reduced.
By People's Daily Online
It is more convenient for A/H1N1 patients to go to community hospitals
Zhong said during his visit to the health service centers, that about half of Guangzhou's patients who saw doctors because of having a cold or fever were flu patients, 90 percent of which were A/H1N1 patients. It is more convenient for A/H1N1 patients to go to community hospitals than large-sized hospitals.
Zhong noted that ordinary treatment is enough for most patients with mild symptoms. Aside from providing treatment services, community health service centers also play a monitoring role. "If there are more flu patients, community health service centers should report to departments at a higher level; if there are many flu patients in a community, the community health service center should take timely preventive and control measures such as quarantine to prevent the spread of the epidemic. Patients can immediately access treatment at community health service centers after contracting the flu, this is the most effective method to prevent and control the A/H1N1 flu," said Zhong.
Pregnant women with A/H1N1 flu symptoms should take the Tamiflu as early as possible
Zhong disclosed that statistics show 80 percent of the over 200 A/H1N1 flu deaths in China have been pregnant women, and the majority of them had been pregnant for more than six months.
Zhong added that once the condition of pregnant women who contracted A/H1N1 flu became severe, it is very difficult to cure and there is a high rate of fetal mortality. He suggested that pregnant women who have A/H1N1 flu symptoms such as fever or cough should receive the Tamiflu injection.
Zhong suggested the community health service centers pay close attention to high-risk groups, such as pregnant women of five to six months and people who have suffered from heart disease or asthma in the past. The A/H1N1 patients who suffer with persistent high fever, body aches and cough, or whose condition worsens quickly in two or three days, should take the Tamiflu as soon as possible.
Zhong also disclosed that at present, China has reserved 26 million doses of Tamiflu, which account for 2 percent of China's population. The Tamiflu will initially be delivered to provinces and cities, and then to villages and communities.
State Food and Drug Administration (SFDA) reaffirmed that the A/H1N1 vaccine is safe.
The SFDA held a routine press conference on December 8.
In the conference, spokesperson Yan Jiangying reaffirmed in terms of the safety of the A/H1N1 vaccine that the Ministry of Health had specially explained the four death cases. The cases occurred after the patients were vaccinated, but they were not directly related to the vaccine. So far, no allergic response to the A/H1N1 vaccine has been found, and the vaccine is safe and effective. Although the SFDA finished the vaccine's examination and approval in a short period of time, the standards were not degraded and the procedures were not reduced.
By People's Daily Online
No comments:
Post a Comment